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SUMMARY 
Estrogens are important regulators of neuronal cell morphology, and this is thought to be 
critical for gender-specific differences in brain function and dysfunction. Dendritic spine 
formation is dependent on actin remodeling by the WASP-family verprolin homologous 
(WAVE1) protein, which controls actin polymerization through the actin-related protein 
(Arp)-2/3 complex. Emerging evidence indicates that estrogens are effective regulators of 
the actin cytoskeleton in various cell types via rapid, extranuclear signaling mechanisms. 
We here show that 17-estradiol (E2) administration to rat cortical neurons leads to 
phosphorylation of WAVE1 on the serine residues 310, 397, and 441 and to WAVE1 
redistribution toward the cell membrane at sites of dendritic spine formation. WAVE1 
phosphorylation is found to be triggered by a Gαi/Gβprotein-dependent, rapid 
extranuclear signaling of estrogen receptor α to c-Src and to the small GTPase Rac1. Rac1 
recruits the cyclin-dependent kinase (Cdk5) that directly phosphorylates WAVE1 on the 
three serine residues. After WAVE1 phosphorylation by E2, the Arp-2/3 complex 
concentrates at sites of spine formation, where it triggers the local reorganization of actin 
fibers. In parallel, E2 recruits a Gα13-dependent pathway to RhoA and ROCK-2, leading to 
activation of actin remodeling via the actin-binding protein, moesin. Silencing of WAVE1 
or of moesin abrogates the increase in dendritic spines induced by E2 in cortical neurons. 
In conclusion, our findings indicate that the control of actin polymerization and branching 
via moesin or WAVE1 is a key function of estrogen receptor α in neurons, which may be 
particularly relevant for the regulation of dendritic spines. (Molecular Endocrinology 23: 
1193–1202, 2009) 
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RIASSUNTO 
Gli estrogeni sono importanti regolatori della morfologia delle cellule neuronali e questo 
sembra essere responsabile delle differenze genere-correlate nelle funzioni e disfunzioni 
cerebrali. La formazione delle spine dendritiche dipende dal rimodellamento actinico da 
parte di WAVE-1 (WASP-family verprolin homologus), che controlla la polimerizzazione 
actinica attraverso Arp2/3 (actin-related protein 2/3). Studi recenti evidenziano che gli 
estrogeni sono i regolatori effettivi del citoscheletro actinico in vari tipi cellulari attraverso 
segnali rapidi extranucleari. In questo studio dimostriamo che il trattamento dei neuroni 
corticali di ratto con 17β-estradiolo (E2)  porta alla fosforilazione di WAVE-1 a livello di 
ser-310, 397 e 441 e alla ridistribuzione di  WAVE-1 sulla membrana cellulare, nei siti di 
formazione delle spine dendritiche. La fosforilazione di WAVE-1 sembra essere innescata 
da un segnale extranucleare rapido dell’ERα (dipendente da una proteina Gαi/Gβ) che 
attiva c-Src e la GTPasi Rac1. Rac1 recluta la chinasi ciclina-dipendente (Cdk5) che fosforila 
direttamente WAVE-1 sui tre residui serinici. Dopo la fosforilazione di WAVE-1, il 
complesso Arp2/3 si concentra nei siti di formazione delle spine dendritiche, dove è 
innescata la riorganizzazione locale delle fibre actiniche. In parallelo, E2 recluta una via 
Gα13-dipendente che attiva RhoA e ROCK-2, portando all’attivazione del rimodellamento 
actinico attraverso la proteina legante l’actina, moesin. Il silenziamento di WAVE-1 o di 
moesin annulla l’incremento delle spine dendritiche indotto dall’E2 nei neuroni corticali. 
In conclusione le nostre scoperte indicano che il controllo della polimerizzazione actinica e 
la ramificazione attraverso WAVE1 è una funzione chiave dell’ ERα nei neuroni,  
particolarmente rilevante per la regolazione delle spine dendritiche. (Mol. Endoc., 2009).
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INTRODUCTION 
OVERVIEW ON ESTROGEN 
Estrogens, like other steroid hormones, are naturally occurring 
cyclopentanophenanthrene compounds whose synthesis begins with cholesterol. 
Estrogens play key roles in development and maintenance of normal sexual and 
reproductive function in both men and women [1]. Although, their levels are significantly 
higher in women of reproductive age. They are mainly produced by the ovary and in part 
by the adrenal cortex, and three estrogens occur naturally in the female [2-3]. In 
premenopausal women, 17β-estradiol (E2), produced by the ovary granulosa, is the 
estrogen produced in the largest quantity and is the most potent as it has the highest 
affinity for its receptors. In pre-menopausal women, circulating estradiol levels fluctuate 
from 40 to 200-400 pg/mL during the menstrual cycle [3]. After menopause, estradiol 
levels drop to less than 20 pg/mL. The second estrogen is estrone (E1), a less potent 
metabolite of estradiol. Estrone is produced from androstenedione, the immediate 
precursor of estrone, in the liver and adipose tissue. In post-menopausal women, the 
ovary ceases to produce estradiol while the adrenal gland continues to produce 
androstenedione. As the result, the level of estrone remains unchanged while the plasma 
level of estradiol falls significantly. The third endogenous estrogen is estriol (E3), also a 
metabolite of estradiol (Fig. A). Estriol is the principal estrogen produced by the placenta 
during pregnancy, and is found in smaller quantities than estradiol and estrone in non-
pregnant women [2-4]. 
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                      Fig. A. The chemical structures of estrone, 17β-estradiol, and estriol. 
 
In the target tissues such as reproductive organs, estrogens exhibit important biological 
functions. Among these, the ovarian cycle, the development of both sexual primary and 
secondary characters are dependent on estrogen [5]. Besides regulation of physiological 
functions in reproductive tissues, estrogens exert a vast range of biological effects and 
influence many other physiological processes in mammals including cardiovascular health, 
bone integrity, cognition, and behaviour [1]. 
Estrogens play important roles in bone homeostasis, being involved in modeling of bone 
during adolescence. They initiate pubertal growth and later limit longitudinal bone growth 
by inducing closure of the epiphysial growth plate. Even in adult life, sex steroids appear 
to influence the remodeling of bone. E2, in particular, is crucial for the maintenance of 
bone mass in females [6] as is evident from the rapid loss of trabecular bone and 
development of osteoporosis that occurs after ovariectomy or at menopause [7-8]. 
Several factors, known to be important in regulating differentiation and function of 
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osteoblasts and osteoclasts, are regulated by E2. In osteoblasts, E2 stimulates synthesis 
and secretion of the anabolic growth factor IGF-I and inhibits that of thecytokines, IL-1, 
tumor necrosis factor (TNF), and IL-6 [9] that are involved in bone resorption [10]. 
Estrogen appears to be protective in the cardiovascular system, in part due to favourable 
modulation of serum lipid profiles [11-12]. The 30% of these effects are due to a reduction 
of total cholesterol by increasing the LDL receptor (LDLr) expression in the liver [13-14] 
and inhibiting the LDLr oxidation at vascular level [15]. Recent evidence indicates that the 
70% of estrogen effect is also due to its direct action on the vasculature, as demonstrated 
by gender differences in smooth muscle contractility, with a greater response to 
noradrenaline or phenylephrine in aortas isolated from male than female rats [16]. E2 
rapidly induces the activity of endothelial nitric oxide synthase (eNOS), which produces 
the vasodilator nitric oxide (NO) [17]. Furthermore, estrogens are able to prevent the 
proliferation and the migration of vascular smooth muscular cells (VSMC) both directly 
[18] and indirectly blocking the mitogenic action of growth factors [19-20]. Prior to 
menopause, women have a lower incidence of coronary heart disease compared with age-
matched men [21-22]. Moreover, estrogen replacement therapy reduces mortality due to 
coronary heart disease in post-menopausal women ([11]. Deprivation of estrogens by 
ovariectomy results in enhanced vascular contraction in aortas of female rats [16]. In 
ovariectomized rats, chronic estrogen replacement suppresses endothelium-dependent 
contractions mediated by the cyclo-oxygenase/prostaglandin H synthase pathway [23]. 
Studies in humans also demonstrate a beneficial vascular action of estrogen, with 
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endothelium-dependent vasodilatation being enhanced by the administration of 17β-
estradiol at physiological levels [24-26]. 
In central nervous system, estrogen has been found to contribute to promote synapse 
formation and plasticity and to limit neuronal damage and death, besides its capability to 
protect from neurodegenerative process. Furthermore, the 17β-estradiol plays an 
important role as antioxidant reducing the oxygen reactive species (ROS) by increasing the 
protein level of tioredoxin, an important protein that protect from lipid peroxidation after 
oxidative stress [27]. 
Postmenopausal women are in an estrogen-deprived state and are at risk for stroke and 
other neurodegenerative diseases [28]. Epidemiological evidence suggests that 
postmenopausal estrogen therapy (ET) reduces the risk or delays the onset of Alzheimer 
disease [29]. Estrogen loss from natural or surgical menopause has been associated with a 
decline in cognitive function [30] that is reversed by ET. ET has been shown to affect 
cognitive function during brain aging as well [31-32]. 
Given this widespread role for estrogen in human physiology, it is not surprising that 
estrogen is also implicated in the development or progression of numerous diseases, 
which include but are not limited to osteoporosis, neurodegenerative diseases, 
cardiovascular disease, insulin resistance, lupus erythematosus, endometriosis, obesity 
and various types of cancer (breast, ovarian, colorectal, prostate, and endometrial). 
Indeed, in addition to proliferative effects on normal cells, estrogen is considered as a 
stimulant for the initiation and promotion of tumors in these organs [5]. This expanded 
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view of estrogen action reflects the findings of a large number of clinical and 
epidemiological studies which gathered on the effects of exogenous estrogen 
administration on the post-menopausal women health. Based on data from both clinical 
and animal studies, estrogen is implicated in the development of breast cancer stimulating 
proliferation of mammary cells by increasing cell division and DNA synthesis [33]. Risk 
factors associated with breast cancer reflect cumulative exposure of the breast epithelium 
to E2 [2, 34]. There is also evidence that estrogens, together with gonadotropins, 
contribute to the etiology of ovarian cancer in humans [33, 35]. Whereas, clinical studies 
indicate that the incidence of colon cancer is lower in women than in men [36], and data 
from the Women’s Health Initiative indicate a significantly reduced incidence of colon 
cancer in postmenopausal women receiving combined ‘Hormone Replacement 
Therapy’(HRT; estrogen plus progestin) [2, 37]. 
 
ESTROGEN RECEPTORS 
The biological actions of estrogens are traditionally mediated by binding to one of two 
specific estrogen receptors (ERs), ERα or ERβ, that are encoded by different genes located 
on different chromosomes (locus 6q25.1 and locus 14q23-24.1, respectively) [38-40]. ERα 
and ERβ, like all the members of the nuclear receptor super-family, are modular proteins 
sharing common regions, named A/B, C, D, and E/F, as well as a high sequence homology 
(Fig. B). These regions participate in the formation of independent but interacting 
functional domains. The N-terminal domain (A/B region) is involved in both inter-
molecular and intra-molecular interactions as well as in the activation of gene 
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transcription. The DNA binding domain (DBD, C region) allows ER to dimerize and to bind 
to the specific ERE sequence on DNA through its two “zinc finger” structures. The hinge 
domain (D region) has a role in receptor dimerization and in binding to chaperone heat-
shock proteins (Hsp). The ligand binding domain (LBD, E/F region, C-terminal) comprises 
the E2-binding domain and works, synergistically with the N-terminal domain in the 
regulation of gene transcription [10, 41-42]. 
  
 
 
Fig. B. A schematic structural comparison of human ERα and ERβ functional domains. Receptor 
domains are illustrated with different colored boxes, and the approximate size of each domain is 
indicated. The A/B domain contains the ligand-independent transcriptional-activation function AF-
1, the C domain represents the DNA-binding-domain (DBD), the D domain corresponds to the 
hinge region, and the E domain contains the hormone-binding domain (LBD) and the hormone-
dependent transcriptional-activation function AF-2. The number inside each box of ERβ refers to 
the percentage of amino acid identity. 
 
ERs contain two regions called activation functions (AFs) important for ligand-dependent 
transcriptional activity (Fig. 1.1) [10, 41-42]. AF-1 and AF-2 regions of ERs, interacting with 
a number of transcription co-activators, can activate transcription independently but in 
A.M. Sanchez                                                   Rapid Signaling of Estrogen in the Brain 
14 
 
most cases, they synergize with one another in a promoter- and cell-context specific 
manner [43]. AF-1 could be activated even in a ligand independent manner, depending on 
the phosphorylation status of ER. In particular, the Ser118 residue in the AF-1 region of 
ERα, as well as residues Ser106 and Ser124 in the AF-1 region of ERβ, are the 
phosphorylation sites essential for the ligand-independent activation of ERs through the 
Ras mitogen activated protein kinase (MAPK) signaling cascade [44]. 
Recent progress in studies on genomic and cDNA sequences has accelerated the 
identification of gene splice variants in the NR super-family. Numerous mRNA splice 
variants exist for both ERs and the best characterized splice variants are ERα46 and ERβcx, 
which are frequently co-expressed with their wild-type counterparts. The exact function 
and potential role of these and other ERs splice variants in physiology and human disease 
remain to be elucidated [45-46]. 
 
ER ACTION MECHANISMS 
The mechanisms of ERα and ERβ action are complex pathways that involve two distinct 
types of signaling which lead to protein kinase activation mediate of rapid or 
“nongenomic” effects (rapid membrane-initiated mechanism) and direct or indirect 
transcription of target genes (nuclear mechanism) (Fig. C). All these pathways synergize 
each other to determine the overall effects of E2. 
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Fig. C. Models of estrogen action. In the “classical” pathway of estrogen action (i), estrogen or 
other selective estrogen receptor modulators (SERMs) bind to the estrogen receptor (ER), a ligand-
activated transcription factor that regulates transcription of target genes in the nucleus by binding 
to estrogen response element (ERE) regulatory sequences in target genes and recruiting 
coregulatory proteins (CoRegs) such as coactivators. Rapid or “nongenomic” effects of estrogen 
may also occur through the ER located in or adjacent to the plasma membrane (ii), which may 
require the presence of “adaptor” proteins, which target the ER to the membrane. Activation of 
the membrane ER leads to a rapid change in cellular signaling molecules and stimulation of kinase 
activity, which in turn may affect transcription. Lastly, other non-ER membrane-associated 
estrogen-binding proteins (EBPs) may also trigger an intracellular response (iii). 
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Membrane initiated signals (MIS) of estrogens 
The nuclear initiated signals of steroid hormones occurs after a time-lag of at least 2 hours 
after E2 stimulation and explains some of hormone functions in physiological and 
pathological situations [47-48]. This picture was challenged when a physiological dose of 
E2 was reported to increase the uterine cAMP level in ovariectomized rats within 15 
seconds, an effect too rapid to be accounted for genomic action(s). This event was not 
abrogated by transcriptional inhibitors and was termed “rapid or nongenomic”. Actually 
the term “non-genomic” is not adequate when referring to rapid changes that may also 
initiate new gene transcription [47, 49]. Various signaling pathways are activated upon E2 
binding to ERs. These rapid events may be classified into four main signaling cascade: 
phospholipase C (PLC)/protein kinase C (PKCs) [13, 20, 50-51], Ras/Raf/MAPK [52-54], 
phosphatidyl inositol 3 kinase (PI3K)/AKT [48, 55-56], and cAMP/protein kinase A (PKA) 
[57-58]. These pathways present numerous interactions with several other pathways 
(Figure D). The ERα:E2 complex interacts with the IGF-1 receptor, leading to IGF-1 
receptor activation and hence to MAPK signaling pathway activation [59]. In addition, the 
ERα:E2 complex activates the EGF receptor by a mechanism that involves activation of 
guanine nucleotide exchange proteins (G-proteins), Src, and matrix metalloproteinases, 
leading to an increase in extracellular regulated kinases (ERK) and PI3K/AKT activities [52, 
59-61]. In endothelial cells the Src/PI3K/AKT pathway mediates rapid E2-dependent 
activation of eNOS and the release of nitric oxide. AKT and PKC could also modulate the 
MAPK pathway through Raf phosphorylation [17, 48, 62]. It is important to note that 
activation of signaling pathways by E2 is cell type-specific. Indeed, the effect of E2 on PKC  
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Figure D. Schematic model illustrating the relationship between the mechanisms of action of E2. 
Palmitoylation (PA) allows the estrogen receptor (ER) localization at the plasma membrane. E2 
binding induces ER association to signaling proteins, and triggers the activation of signaling 
cascades. The kinase activations phosphorylate ER, modulate transcriptional coactivators 
recruitment, and enhance AP-1 and Sp-1 activation. After dimerization ERs directly interact with 
ERE on DNA. ERs-DNA indirect association occurs through protein-protein interactions with the Sp-
1 and AP-1 transcription factors. 
 
activity has been observed in the preoptic area of female rat brain slices, but not in the 
hypothalamus or cortex [63]. The activation of G-protein/Src/PI3K/MAPK pathway by E2 
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was evident in late, but not early, differentiated rat pre-adipocytes ([52]. The differential 
requirement of Src/PI3K or intracellular calcium for MAPK activation is also observed in 
diverse cell types [52, 60]. Different PKC isoforms are rapidly activated by E2 in HepG2 and 
MCF7 cells [50]. As a whole, these studies indicate that the rapid actions of E2 depend on 
a number of conditions such as the set of signal transduction molecules and downstream 
targets present in the target cell, thus the responses are likely to be diverse. All these 
results point to the concept that ERα is the primary endogenous mediator of rapid E2 
actions. 
 
Nuclear signals (NS) of estrogens 
In the “classical” mechanism of action, estrogens diffuse into the cell membrane and bind 
to ERs causing ERs to dissociate from heat shock proteins, to dimerize and to traslocate 
into the nucleus. The nuclear ERα- or ERβ-E2 complex directly binds DNA through the ERE 
(estrogen responsive element) sequences or indirectly through protein-protein interaction 
with activator protein-1 (AP-1) or stimulating protein (Sp-1), resulting in recruitment of 
coregulatory proteins (coactivators or corepressors) to the promoter, increased or 
decreased mRNA levels, protein synthesis, and physiological responses ([2, 33] (Figure C-
E). A large subset of coregulatory proteins (e.g., steroid receptor coactivator-1, 2, and 3) 
helps the hormone-receptor complex to recruit histone acetyltransferases and 
methyltransferases which, in turn, possess chromatin remodeling ability and tether 
activated receptors to the basal transcriptional machinery [64]. Both ERα and ERβ are 
capable of regulating gene transcription through this classical mechanism involving ERE. 
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ERβ seems to be a weaker transactivator [65]. AF-1 activity of ERβ is weak compared with 
that of ERα on ERE, whereas their AF-2 activities are similar [65]. In turn, when both AF-1 
and AF-2 functions are active in a particular cell and/or on a particular promoter, the 
activity of ERα greatly exceeds that of ERβ, whereas ERα and ERβ activities are similar 
when only AF-2 is required [2, 66]. It has been postulated that differences in the ERα and 
ERβ activities are due to differences in the ability of the receptors to interact with 
coregulatory proteins, because of the low amino acid identity in A/B domain of ERs (Figure 
B) [2, 64]. 
Another category of gene promoters, lacking any ERE-like sequences, requires a second 
DNA-binding transcription factor (e.g., Sp-1 and AP-1) to mediate ER association with the 
DNA [67] (Figure E). Although ERα and ERβ have similar effects on ERE-mediated gene 
transcription, the receptors show opposite effects on promoters containing AP-1 [68]. E2 
activates AP-1-mediated gene transcription when bound to ERα but inhibits promoter 
activity when bound to ERβ [68]. The converse is true for anti-estrogens, such as 
tamoxifen, raloxifene, and ICI 164384, which are AP-1 transcriptional suppressors via ERα 
and activators via ERβ [68-69]. Similar to AP-1, E2 binding to ERα induces transcriptional 
activation when associated with Sp-1 in GC-rich regions. However, E2 binding to ERβ does 
not result in the formation of a transcriptionally active complex at a promoter containing 
Sp-1 elements [70]. Consequently, these differences in transcriptional activity between 
the ERα and ERβ may account for the major differences in their tissue specific biological 
actions. 
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Figure E. Schematic model illustrating the action mechanisms of E2. In the first panel (a) is 
depicted the classical interaction of the activated receptor with ERE on DNA. In panels b and c are 
representations of the indirect effects of ERs on transcription interactions. This occurs through 
protein-protein interactions with the Sp1 (b), AP-1 (c). The panel d represents the E2-non-genomic 
mechanism. AP-1, activating factor-1; Sp-1, stimulating factor-1. 
 
ROLE OF ESTROGEN IN THE BRAIN 
Estrogen and cell movement   
Sex steroid hormones are fundamental regulators of cell growth, proliferation, and 
migration. Indeed, estrogens direct the development of several tissues and organs [71] 
and orchestrate cell growth and proliferation during adult life [72]. Cells respond to the 
environment through the expression of transmembrane receptors that sense extracellular 
stimuli and activate an elaborate network of intracellular signaling molecules. Given the 
large number of different signaling molecules and the complex relationships between 
them, a major challenge is to understand how specific signals generate unique responses. 
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The architecture of signaling networks plays an important role in achieving signaling 
specificity [73]. 
The control of cell morphology and of the interaction of the cell with the extracellular 
environment requires a number of regulators orchestrating the different cytoskeletal 
components and their interactions with the cell membrane and with anchorage proteins 
[74]. Recent findings indicate that extra-nuclear signaling of estrogen is a fundamental 
regulator of cell morphology in diverse cellular lines, including neuronal cells [75-76], and 
that many of these actions are played via rapid signaling to the actin cytoskeleton 
achieved via actin recruitment [77-78]. 
The brain is an important target of sex steroids, like estrogen, that plays multiple 
regulatory roles. These hormones are powerful mediators of dynamic brain differentiation 
into a male or female phenotype. This phenomenon has been originally described in 
studies on neuronal cell migration in the developing pre-optic area/anterior hypothalamus 
[79]. The effects of sex hormones turn into differences in neuronal cell number, glial 
complexity, neurochemical expression and synaptic connectivity [80] and are related to 
estrogens in the brain. Estrogen acts as neurotrophin regulating cell death, neurogenesis, 
neurotransmitter plasticity, neuronal migration and synaptogenesis [81] and dynamically 
modulates brain ontogeny by influencing neuronal cell movement [82-83]. 
In the recent years, the knowledge on how estrogen interferes with mammalian brain 
functions and development has broadened substantially. In the adult brain, estrogen is 
not only involved in the neuroendocrine feedback regulation at the hypothalamic and 
A.M. Sanchez                                                   Rapid Signaling of Estrogen in the Brain 
22 
 
pituitary level but also in the control of motor and cognitive functions. After the 
demonstration that the estrogen-synthesizing enzyme aromatase and both estrogen 
receptor α and β isoforms are expressed in many brain areas during ontogeny, it was soon 
realized that estrogen modulates neuronal differentiation, notably by influencing cell 
migration, survival and death, and synaptic plasticity of neurons. These effects were 
initially seen in the classical target area for estrogen, the hypothalamus, but later studies 
revealed actions of estrogen also in other regions. Estrogens do not act only on the early 
stages of neuronal development but also on mature neurons for the maintenance and 
reorganization of dendritic structures. Dendrites are the principal cellular sites where 
neurons receive, process, and integrate inputs from their multiple pre-synaptic partners. 
Both the shape of dendritic trees and the density and shape of their spines can undergo 
significant changes during the development and life of a neuron. Dendritic spines are 
composed from actin microfilaments that undergo to dynamic remodeling responsible for 
brain development of neuronal circuits under the regulation of several extracellular 
stimuli [84]. Estrogen is involved in the formation of dendritic spines during development 
and of their structural plasticity at mature synapses, increasing dendritic spine density 
through the dynamic control of actin filaments [85] (Fig. F). 
One of the most intriguing actions that these hormones perform is the control of brain 
plasticity, that is thought to be critical for key functions of this organ, such as memory, 
learning and making cognition possible via neuronal/glial remodeling [86-87]. At the basis 
of brain plasticity is the ability of neurons and glial cells to remodel their mutual 
connections which requires major changes in cell morphology [88-89].  
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Figure F. Complete neuron cell diagram. Neurons (also known as neurones and nerve cells) are 
electrically excitable cells in the nervous system that process and transmit information. In 
vertebrate animals, neurons are the core components of the brain, spinal cord and peripheral 
nerves. 
 
These morphological modifications are tightly dependent on the generation of dynamic 
structural changes of the actin cytoskeleton, via actin polymerization and de-
polymerization that also represent the starting platform for other important cellular 
processes such as cytokinesis, adhesion and motility. When a cell remodels its shape, the 
actin cytoskeleton is reorganized, and protrusive membrane structures, such as 
lamellipodia and filopodia, are formed at the leading edge. These structures generate the 
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locomotive force in migrating cells and are critical in the generation of cell–cell 
interconnections [74]. 
Clinical studies also suggest that the lack of estrogens, such as in women after the 
menopause, may be related to the progression of brain degenerative diseases, like 
Alzheimer’s Dementia or Parkinson’s disease [90-91], and the hypothesis that estrogen 
administration to postmenopausal women might decrease the progression of these 
conditions is lingering [92]. 
 
Estrogen and the cytoskeleton 
The cytoskeleton is an organized structure formed by the connection of three different 
types of filaments: actin, microtubules and intermediate filaments. These cytoskeletal 
complexes interact together as a dynamic network contributing to cell functions such as 
structural integrity, shape, division and cell motility. Indeed, in most animal cells, the 
cytoskeleton is the primary actor in creating the driving forces through which cells move 
[93-94]. Actually, although other non-actin cytoskeletal complexes aid in coordinating cell 
movement and in empowering translocation, the actin cytoskeleton through highly 
dynamic remodeling and continuous creation of new actin networks is considered 
essential for pushing the cell forward in the surrounding environment [74], especially at 
front membrane cell protrusions that allow the very first steps of cell motility. This 
restructuring of cell shape is achieved with the help of a number of accessory proteins and 
signaling pathways [95] that mediate signals of growth factor and cytokines. 
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Estrogens are fundamental modulators of cell morphology and motility in different cellular 
lines. Binding their receptors sex hormones may modulate different rapid intracellular 
cascades such as G protein, tyrosine kinase, c-Src, small GTPases, and protein kinases 
pathways finally leading to the activation of actin remodeling and cell movement. In this 
context, we have recently described how the treatment of diverse cell lines with 
physiological doses of estradiol led to a rapid remodeling of actin cytoskeleton with a loss 
of stress fibers [77-78]. This cytoskeletal rearrangement, associated with the development 
of specialized cell membrane structures such as ruffles and pseudopodia, is obtained 
through the activation of the actin-regulatory protein, moesin [77-78]. A number of 
studies underlined the fundamental contribution of the ezrin–radixin–moesin (ERM) 
family of proteins to cytoskeletal processes responsible for many vital cellular functions 
such as cell motility [96]. 
 
Moesin and actin remodeling 
Moesin, a member of the ezrin/radixin/moesin (ERM) family, is an actin-binding protein 
that plays an important role in cell motility by linking the actin cytoskeleton to a variety of 
membrane anchoring proteins [97-98]. In quiescent conditions moesin exists in an auto-
inhibited conformation and phosphorylation of Thr558 within the C-terminal actin-binding 
domain by the Rho-associated kinase (ROCK), results in a conformational change and in 
the association with the scaffold protein, ezrin/radixin/moesin-binding protein 50 (EBP50) 
on moesin’s NH2-terminal end and with F-actin on moesin’s COOH-terminal end to 
mediate the linkage of microfilaments to membranes in cell surface microvilli [99-100]. 
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Estrogen activates moesin in breast cancer and endothelial cells through a rapid, extra-
nuclear signaling cascade originated by the interaction of ERα with the G protein Gα13. 
This process leads to the recruitment of RhoA and of the Rho-associated kinase, ROCK-2 
and to moesin activation. This pathway leads to the formation of membrane ruffles and 
pseudopodia which interact with the extracellular matrix and with nearby cells, thus 
promoting cell migration [77-78]. Estrogen exposure leads to rapid modifications of the 
cytoskeleton’s organization and to modified interaction with the surrounding environment 
and nearby cells [77-78, 101]. The control of cell morphology may well also be relevant for 
the actions of estrogen in the central nervous system, where morphological changes in 
neuron/neuron interconnections and dendritic spine density ensue related to the cyclical 
changes in estrogen levels [102-103].  
 
WAVE1 and spine dendrite formation 
A large amount of literature supports a key role of the Rho family of GTPases (Rho, Rac1 
and cdc42) in coordinately regulating the polymerization of the actin cytoskeleton and 
turnover during cell migration [104] through the activation of different downstream 
effectors such as c-Src kinase, PI3K (phosphoinositide-3 kinase), PTEN phosphatase (which 
converts phosphoinositides PIP3 into PIP2) and the WASP family of proteins. The discovery 
of this group of cytoskeletal-regulatory proteins has contributed to clarify the molecular 
basis of cell movement. Indeed, signaling from Rho small GTPases to the Arp2/3 complex, 
the WASP family members WASP, N-WASP and WAVE promote the formation and 
branching of actin filaments [105-107] (Figure G). In particular, WAVE1 protein that is  
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Figure G. Model of actin nucleation by WASP-ARP complex 
 
regulated by Rac1 plays a key role also in the induction of actin branching and dendrite 
spine formation [108]. 
The WAVE1 complex seems to be transported by kinesin-1, and this transport has been 
suggested to be important for axon elongation [109]. Several reports have also indicated 
the involvement of N-WASP in spine formation [106, 110-111]. Phosphorylation and de-
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phosphorylation of WAVE1 are also involved in spine formation. Kim et al. recently 
reported that the WAVE1 complex was active during spine formation, and that cyclin 
dependent kinase-5 (CDK5) phosphorylates the proline-rich region of WAVE1 in the 
WAVE1 complex. The phosphorylation sites in the proline rich region of WAVE1 are not 
conserved in WAVE2 and WAVE3 [112]. Loss of WAVE1 function in vivo or in cultured 
neurons results in a decrease in mature dendritic spines [112], suggesting that 
phosphorylation/de-phosphorylation of WAVE1 in neurons has an important role in the 
formation of the filamentous actin cytoskeleton, and thus in the regulation of dendritic 
spine morphology, critical for the development and maintenance of these structures. 
Indeed, WAVE1 knockout mice exhibit deficits in learning and memory [113], suggesting 
the intriguing hypothesis that the increased prevalence of cognitive impairment and of 
some degenerative disorders observed in conditions of estrogen withdrawal might to 
some extent be due to the lack of WAVE1 control by these steroids in brain cells. Thus, the 
finding that estrogen controls neuronal cell morphology through the rapid modulation of 
WAVE1 heralds promises from both the biological and medical perspective, like 
Alzheimer’s Dementia or Parkinson’s disease. 
Although this is a relatively recent area of investigation, it significantly expands our 
perception of the scope of estrogens non-genomic signaling and sheds new insight into 
their ability on the control of cell movement, which may be critically relevant for a various 
of physiological or pathophysiological processes. Given the critical action of WASP family 
proteins on actin remodeling and cell motility, an interesting open question remains the 
role played by sex hormones, as suggested by recent observations [114].    
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Role of estrogen receptor alpha (ERα) in WAVE1 and moesin regulation 
Estrogen plays an important role in changes taking place in the brain through the regulation of 
growth and differentiation of axons and dendrites, influence on plasticity, support of survival as 
well cognitive and behavioral functions. The classical mode of estrogen action is through the 
activation of its receptors. Estrogen receptor (ER) presents two isoforms, ER alpha (ERα) and ER 
beta (ERβ) [115]. 
The interaction of ERα with Gαi and Gβ has been recently reported in endothelial cells [116].  
Consistent with our previous results in endothelial and breast cancer cells [78, 117], ERα is also 
able to interact with Gα13 in the presence of E2. Through the activation of Gα13 at the cell 
membrane, ERα has a privileged access to the pathways that signal to the actin cytoskeleton. In 
fact, Gα13 is responsible for the activation of the RhoA/ROCK-2/moesin cascade pathway [118], 
and may be this pathway is also functional in estrogen-induced neuronal movement. 
On the other hand, WAVE1 signaling cascade is recruited via Cdk5. This leads to intracellular 
localization of WAVE1 at the cell membrane where it drives the accumulation of actin filaments 
and increases the mechanical force necessary for neurite extension and growth-cone 
translocation. Increasing evidence indicates that a number of dynamic functional modifications 
induced by estrogens in neurons are plaid via rapid extra-nuclear signaling pathways recruited by 
estrogen receptors at the cell membrane or within the cytoplasm [101, 119], in various cell types, 
including neurons [120-121]. These rapid signaling actions of estrogen receptors render estrogens 
flexible modulators of neuronal function. It is intriguing to find that the modifications of the 
neuronal cytoskeleton and cell membrane are achieved through this category of action of 
estrogen receptors. Whether such rapid modifications of the structure of neuronal membrane and 
of the number of dendritic spines can in any way be related to changes in neuronal function that 
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could lead to improved or preserved cognition or memory is difficult to say. However, it is well 
established that brain function undergoes rapid modifications in the presence of changing 
estrogen concentrations, as shown by animal models and by the brain originated disturbances 
(e.g. vasomotor symptoms) seen after delivery or menopause, supporting the idea that sex 
steroids, including estradiol might have a role as fast regulators of central nervous system 
function. 
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AIMS 
The aim of the present study was to explore the molecular basis of the action of 17β-
estradiol on cortical neuronal cells morphology. In particular, we wished to identify 
whether these actions may require the regulation of the actin cytoskeleton via WAVE1 or 
moesin and to characterize the intracellular cascades that may be recruited during this 
signaling. 
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RESULTS 
Estrogen induces rapid cytoskeletal and cell membrane remodeling and dendritic spine 
formation in cortical neurons 
As a first step in identifying the effects of estrogen on neuronal morphology, we studied 
the actions of a rapid estrogen exposure on the actin cytoskeleton. Treatment with 17-
estradiol (E2, 10 nM) resulted in a rapid change in actin organization, with a remodeling of 
the actin cytoskeleton toward the cell membrane resulting in a thickening of the 
membrane (Fig. 1, A–C). This phenomenon was time dependent and transient, being 
maximal after 15–20 min and reversing to baseline after 60 min (Fig. 1, A–C). In parallel, 
an increased number of dendritic spines was found that followed the same time course 
(Fig. 1, A and D).  
 
Estrogen rapidly induces WAVE1 and moesin phosphorylation  
WAVE1 is regulated by phosphorylation on three serine residues in the proline-rich 
domain (Ser310, Ser397, and Ser441) [112]. Treatment with E2 (10 nM) rapidly increased 
the phosphorylation of WAVE1 on all three serine residues along a temporal pattern that 
was consistent with that of actin remodeling (Fig. 2, A and B). In parallel, E2 induced a 
dynamic phosphorylation on Thr558 of the actin-binding protein moesin (Fig. 2C), which is 
responsible for triggering actin remodeling toward the membrane in endothelial and 
breast cancer cells [78, 117]. Upon exposure to E2, WAVE1 was redistributed toward the 
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plasma membrane, in particular along the dendritic protrusions (Fig. 2D), in parallel with 
actin and cell membrane remodeling (Fig. 2, E and F). 
To test whether actin remodeling by WAVE1 or moesin is required for the estrogen-
dependent membrane rearrangement in neurons, we silenced WAVE1 with small 
interfering RNAs (siRNAs) and moesin with antisense phosphorothioate oligonucleotides 
(PONs). WAVE1 expression was significantly reduced when neurons were transfected for 
48 h with WAVE1 siRNAs (supplemental Fig. A, published as supplemental data). In 
WAVE1-silenced neurons, E2 failed to induce actin reorganization (Fig. 2, G and H). Moesin 
silencing resulted in lack of actin remodeling in response to E2, in the absence of any 
modification of WAVE1 expression or localization (Fig. 2, G and H). As control, transfection 
of a sense (inactive) oligonucleotide for moesin had no effect on cytoskeletal changes or 
WAVE1 expression during E2 administration (Fig. 2, G and H). 
 
Estrogen regulates WAVE1 via estrogen receptor α (ERα) 
Phosphorylation of WAVE1 induced by E2 identified as a shift in the gel migration was 
prevented by the pure ER antagonist ICI 182,780 (100 nM) (Fig. 3A). To identify which ER 
isoform mediates the signaling of E2 to WAVE1, we used the preferential ERα agonist 
4,49,40-(4 propyl-[1H]- yrazole-1,3,5-triyl) trisphenol (PPT, 10 nM) or the ERβ agonist 2,3-
bis(4-hydroxyphenil)-propionitrile (DPN, 10 nM). WAVE1 phosphorylation was detected 
only in the presence of E2 or PPT, suggesting that ERα supports the signaling to WAVE1, 
whereas ERβ is not required (Fig. 3A). To substantiate this observation, we silenced ERα in 
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cortical neurons with siRNAs. This resulted in a reduction of ERα expression, along with a 
dramatic decrease in WAVE1 phosphorylation on all three serine sites during exposure to 
estrogen (Fig. 3, B and C). This happened in the absence of modifications of the expression 
of WAVE1 or ERβ (Fig. 3B). In agreement, remodeling of actin and cell membrane 
localization of WAVE1 induced by E2 were prevented by ICI 182,780 and supported by the 
ERα agonist PPT but not by the ERβ-selective agonist DPN (supplemental Fig. B).  
 
ERα signals to WAVE1 via a G protein/c-Src initiated cascade 
 To look for the cascades involved in the signaling of ERα to WAVE1 in neurons, we used a 
variety of approaches to interfere with E2 signaling to WAVE1. PD98059 (5 mM), which 
inhibits the ERK1/2 MAPK, and wortmannin (30 nM), an inhibitor of phosphatidylinositol-3 
kinase, were unable to reduce the phosphorylation of WAVE1 by E2 (supplemental Fig. C). 
WAVE1 phosphorylation was instead prevented by the G protein inhibitor pertussis toxin 
(PTX, 100 ng/ml) and by the inhibitor of c-Src, PP2 (0.2 µM) (supplemental Fig. C), 
indicating that ERα recruits a G protein/c-Src cascade to WAVE1. 
 
Interaction of ERα with Gαi and Gβ is required to E2 signaling to c-Src 
Consistent with the previous results, E2 administration resulted in c-Src phosphorylation 
in neurons (Fig. 4A). c-Src phosphorylation was prevented by PTX and by inactivating the G 
proteins Gαi and Gβ with either a dominant-negative construct or with specific siRNAs but 
not by inactivating Gα13 with a dominant-negative construct (Fig. 4A). The interaction of 
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ERα with Gαi and Gβγ has been recently reported in endothelial cells [116]. With co-
immunoprecipitation experiments, we also find a ligand-induced interaction of ERα with 
Gαi1 and Gβ1 (Fig. 4, B and C).  During E2 induced binding of ERα with Gβ1, the interaction 
of Gαi1 and Gβ1 is decreased (Fig. 4C). Consistent with our previous results in endothelial 
and breast cancer cells [78, 117], ERα is also able to interact with Gα13 in the presence of 
E2 (Fig. 4D).  
c-Src is a transducer of signals from G proteins to small GTPases [122], and WAVE is 
involved in actin reorganization and in the formation of membrane ruffles induced by the 
small GTPase Rac1 [123]. We thus studied whether Rac1 is recruited during the signaling 
of ERα to WAVE1. Indeed, during treatment with E2, cortical neurons transfected with a 
Rac1 dominant-negative construct did not show an enhanced WAVE1 phosphorylation but 
actually displayed a slight decrease vs. baseline (Fig. 4E). Rac1 is recruited downstream of 
c-Src, because the Rac1 dominant-negative construct does not impair activation of c-Src 
by E2 (supplemental Fig. D).  
Blockade of G proteins (with PTX), c-Src (with PP2), or Rac1 (with the dominant-negative 
construct) all resulted in a visible inhibition of WAVE1 membrane translocation and of 
actin remodeling induced by E2 (supplemental Fig. E), indicating that a signaling cascade 
involving G proteins, c-Src, and Rac1 mediates the regulatory effects of E2 on WAVE1 in 
cortical neurons. 
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Estrogen signals to WAVE1 via cyclin-dependent kinase 5 (Cdk5) 
Cdk5 phosphorylates WAVE1 on the serine residues Ser310, Ser397, and Ser441 (12). To test 
the requirement of Cdk5 for estrogen signaling in neuronal cells, we immunoprecipitated 
Cdk5 and used the immunoprecipitates (IPs) to perform kinase assays using 
dephosphorylated histone H1 as the target for serine phosphorylation. E2 administration 
resulted in a rapid increase in Cdk5 activity, which was sensitive to roscovitine (50 µM), a 
selective inhibitor of Cdk5 (Fig. 5A). Cdk5 activation in the presence of E2 was also 
prevented by the c-Src inhibitor (PP2) as well as by transfection of a Rac1 dominant-
negative construct (Fig. 5B), overall suggesting that ERα recruitment of c-Src and Rac1 
leads to Cdk5 activation. 
Consistent with this hypothesis, WAVE1 phosphorylation on the three Cdk5 target sites 
induced by E2 was inhibited by roscovitine (Fig. 5C). In addition, transfection of neurons 
with three constructs encoding for WAVE1 with serine to alanine mutations [112] deleting 
the Cdk5 serine phosphorylation sites (Fig. 5D) resulted in decreased dendritic spine 
density, particularly with the mutated Ser310 construct (S310A-WAVE1) (Fig. 5, E and F), 
confirming the hypothesis that E2 regulates WAVE1 and dendritic spine formation via 
Cdk5. 
 
Differential signaling of ER to moesin and WAVE1 in neurons 
To confirm that ERα recruits different signaling avenues to regulate moesin and WAVE1, 
we exposed neurons to E2 (10 nM) during the blockade of Gαi, Gβ, c-Src, Rac1, and Cdk5 
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(involved in the signaling to WAVE1) or of Gα13, RhoA, or Rho-associated kinase (involved 
in signaling to moesin). Western analysis of WAVE1 and moesin phosphorylation showed 
that the blockade at any level of the c-Src/Rac1/Cdk5 cascade results in impaired 
phosphorylation of WAVE1 but not of moesin (Fig. 5G). Conversely, blockade of the 
Gα13/RhoA/Rho associated kinase impairs moesin phosphorylation by E2 but not WAVE1 
phosphorylation (Fig. 5G). Blockade of Gαi or Gβ resulted in inhibition of both moesin and 
WAVE1 phosphorylation, suggesting that these two G proteins may be involved in 
downstream signaling to these actin regulators via multiple pathways. 
 
Estrogen signaling to WAVE1 results in Arp-2/3 membrane translocation 
Actin nucleation by the Arp-2/3 complex is critical for the rapid formation of an actin 
network at the leading edge of cells [124]. In response to Rac1, the Arp-2/3 complex 
initiates the formation of lamellipodia. WAVE1 acts as a scaffolding complex relaying 
signals from small GTPases to the Arp-2/3 complex [125]. 
Cortical neurons treated with E2 displayed a membrane translocation of Arp-2 that was 
time consistent with the phosphorylation of WAVE1 (Fig. 6, A and B). Blockade of c-Src 
with PP2 or of Rac1 by transfection of a dominant-negative construct or of Cdk5 with 
roscovitine blocked the estrogen-induced membrane translocation of Arp-2, supporting 
the concept that estrogen signals to WAVE1 and Arp-2 through a c-Src/Rac1/Cdk5 
cascade. 
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Estrogen regulates the formation of dendritic spines via WAVE1 and moesin in cortical 
neurons 
The formation of excitatory synaptic connections in neurite extensions is dependent on 
the development of actin-rich dendritic spines [108]. Actin staining in cortical neurons 
demonstrated a net enrichment in dendritic spine density after treatment with E2 (Fig. 7, 
A and B). Silencing of WAVE1 with siRNAs significantly decreased the number of spines 
induced by E2 (Fig. 7, A and B). As control, the transfection of a siRNA-resistant WAVE1 
construct reversed the effect of the siRNA (Fig. 7, A and B). Moesin silencing with specific 
PONs also prevented the increase in dendritic spines by E2 (Fig. 7, A and B). 
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DISCUSSION 
The control of cell morphology and of the interaction of the cell with the extracellular 
environment requires a number of regulators orchestrating the different cytoskeletal 
components and their interactions with the cell membrane and with anchorage proteins 
[74]. These phenomena are key determinants of brain plasticity, making cognition, 
memory, or learning possible via neuronal/glial remodeling [89]. Dendrites are the sites 
where neurons receive, process, and integrate inputs from their multiple presynaptic 
partners. Both the shape of the dendritic trees and the density and shape of their spines 
can undergo significant changes during the development and life of a neuron. Dendritic 
spines are composed mainly of actin microfilaments that undergo a continuous 
remodeling that is important for the development of neuronal circuits [84]. 
Estrogens stimulate the formation of dendritic spines as early as during embryonic 
neuronal development and continue to act on mature neurons regulating their structural 
plasticity at mature synapses and increasing dendritic spine density through the dynamic 
control of actin filaments [85]. 
The key finding of this work is that ERα uses the actin controllers WAVE1 and moesin in 
neurons to induce a rapid cytoskeletal remodeling that supports the formation of 
dendritic spines. In the presence of its ligand, ERα recruits a Gαi-Gβ/c-Src/ 
Rac1/Cdk5/WAVE1 cascade (Fig. 8). This turns into WAVE1 phosphorylation and 
translocation to the sites where the actin cytoskeleton and the cell membrane are actively 
remodeled and in the parallel membrane localization of the Arp-2/3 protein complex, 
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which is responsible for the extension and branching of actin filaments and thus for cell 
membrane remodeling. The parallel recruitment of the Ezrin/Radixin/Moesin (ERM) actin-
binding protein, moesin, via a Gα13/RhoA/ROCK-2 cascade (Fig. 8) contributes to the 
remodeling of the cytoskeleton and is required for the estrogen-induced dendritic spine 
formation. 
Recent evidence on cultured neurons and in intact mice shows that loss of WAVE1 results 
in a dramatic decrease in mature dendritic spines [112], suggesting that in neurons, the 
regulation of the actin cytoskeleton is critical for the development and maintenance of 
these structures. Thus, the finding that estrogen controls neuronal cell morphology 
through the rapid modulation of WAVE1 heralds promises from both the biological and 
medical perspective. Indeed, WAVE1 knockout mice exhibit deficits in learning and 
memory [113], suggesting the intriguing hypothesis that the increased prevalence of 
cognitive impairment and of some degenerative disorders observed in conditions of 
estrogen withdrawal might to some extent be due to lack of WAVE1 control by these 
steroids in brain cells. 
When E2 hits ERα, a signaling cascade to Cdk5 is recruited. This leads to intracellular 
localization of WAVE1 at the cell membrane where it drives the accumulation of actin 
filaments and increases the mechanical force necessary for neurite extension and growth-
cone translocation. Although all the three identified WAVE proteins are known to localize 
at growth cones, their respective roles are unclear [126]. The WAVE1 complex seems to be 
transported by kinesin-1, which has been suggested to be particularly important for axon 
elongation [108], whereas other reports indicate an involvement of neural WASP in spine 
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formation [111]. Phosphorylation and dephosphorylation of WAVE1 seem to be necessary 
for spine formation, as well. During spine formation, the WAVE1 complex is 
hyperphosphorylated on the proline-rich region by Cdk5, resulting in a later functional 
regulation of the Arp-2/3 complex [126]. Thus, Cdk5-dependent phosphorylation of 
WAVE1 and the subsequent Arp-2/3-mediated branching of actin is a newly identified 
mechanism by which dendritic spine formation is regulated by estrogen. It is likely that 
this phenomenon results from the synergic regulation of multiple converging pathways, as 
suggested by the seemingly paradoxical reduction of WAVE1 phosphorylation induced by 
E2 during Rac1 blockade. This suggests that E2 also recruits a yet unidentified inhibitory 
pathway that reduces Cdk5 phosphorylation of WAVE1 that is independent of Rac1 (Fig. 
8). In addition, the requirement of moesin for optimal cytoskeletal remodeling and spine 
formation also stands for the existence of an integrated signaling network enacted by ERs 
in neurons to control the architecture of the cytoskeleton. 
Increasing evidence indicates that a number of dynamic functional modifications induced 
by estrogens in neurons are made via rapid extranuclear signaling pathways recruited by 
ERs at the cell membrane or within the cytoplasm [101, 119], in various cell types, 
including neurons [120-121]. These rapid signaling actions of ERs render estrogens flexible 
modulators of neuronal function. It is intriguing to find that the modifications of the 
neuronal cytoskeleton and cell membrane are achieved through this category of action of 
ERs. Whether such rapid modifications of the structure of neuronal membrane and of the 
number of dendritic spines can in any way be related to changes in neuronal function that 
could lead to improved or preserved cognition or memory is difficult to say. However, it is 
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well established that brain function undergoes rapid modifications in the presence of 
changing estrogen concentrations, as shown by animal models and by the brain originated 
disturbances (e.g. vasomotor symptoms) seen after delivery or menopause, supporting 
the idea that sex steroids might have a role as fast regulators of central nervous system 
function. 
In conclusion, we here show that estrogens are implicated in neurite extension in 
neuronal cells acting through rapid, extranuclear signal transduction pathways recruited 
by ERα. Estradiol acts through the activation of G proteins via ERα, leading to the 
recruitment of a c-Src/Rac1/Cdk5/WAVE1/Arp-2/3 cascade. Through this cascade, E2 
supports the rearrangement of the actin cytoskeleton at sites of ongoing spine formation 
in cortical rat neurons. The parallel G protein-dependent activation of the RhoA/ROCK-
2/moesin cascade contributes to this phenomenon. The identification of these original 
rapid actions of estrogen in brain cells increases our understanding of the complex actions 
of sex steroids in the central nervous system and may provide new tools to interfere with 
some of the gender-related degenerative changes observed in the brain throughout aging. 
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MATERIALS AND METHODS 
Neuronal cell cultures 
Primary cultures of cortical neurons were obtained from embryonic day 18 rat fetuses as 
described [75]. Cortical cells were dissected with 0.02% trypsin (Invitrogen) for 5 min at 
37°C and then dissociated. Cells were plated on poly-D-lysine-coated 60 mm Petri dishes 
at a density of 0.5–1 x 105 cells/cm2. Neurons were grown in Neurobasal medium 
(Invitrogen) supplemented with 10 U/ml penicillin, 10 µg/ml streptomycin, 0.5mM 
glutamine, 25 µM glutamate, and 2% B27 (Invitrogen). These culture conditions generate 
cultures that are > 95% neuronal and ≤ 5% glial [127]. 17β-estradiol, PTX, PD98059 and 
wortmannin were from Sigma-Aldrich (Saint-Louis, MO); roscovitine and PP2 were from 
Calbiochem; ICI 182,780, PPT and DPN were obtained by Tocris Cookson (Avonmouth, UK). 
Whenever an inhibitor was used, the compound was added 30-45 minutes before starting 
the treatments. 
 
Immunoblottings 
Cell lysates were separated by SDS-PAGE (8-12%). Immunoblottings were performed with 
antibodies against: Histone H1, Phospho-Histone H1 (P-Ser27), WAVE1 (Sigma-Aldrich 
Laboratories); Actin (C-11), Arp2 (H-84), ERα (H-184), ERβ (N-19), c-Src (H-12), Rac1 (C-14) 
(Santa Cruz Biotechnology, Santa Cruz, CA); Cdk5 (268-283) (Calbiochem); Phospho-Src 
(Tyr416) (Cell Signaling Technology); WAVE1 (c-term), Phospho-Ser310-WAVE1, Phospho-
Ser397-WAVE1, Phospho-Ser441-WAVE1. Primary and secondary Abs were incubated with 
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the membranes with standard technique. Immunodetection was accomplished using 
enhanced chemiluminescence. Chemiluminescence was acquired with a quantitative 
digital imaging system (Quantity One, BioRad, Hercules, CA) allowing to check for 
saturation. Overall emitted photons were quantified for each band, particularly for loading 
controls, which were homogeneously loaded. 
 
Immunoprecipitations 
Primary cortical neurons were washed with ice-cold PBS and lysed with: 20mM Tris-HCl, 
pH 7.4, 10 mM EDTA, 100 mM NaCl, 1% Igepal, 1 mM Na3VO4, 50 mM NaF, 0.1 mg/L 
PMSF, 0.3 mg/L aprotinin, and 0.01% protease inhibitor mixture (Sigma-Aldrich 
Laboratories). The immunoprecipitating antibody Arp-2 (2 µg) was added to equal 
amounts of cortical neuron lysates (0.5–1 mg) in 500 µl of lysis buffer for 1 h at 4°C with 
gentle rocking. Subsequently, 40 µl of 1:1 Protein-A-agarose was added and gently rocked 
for 2 additional hours at 4°C. The mixture was then centrifuged at 12,000 x g for 5 min at 
4°C. The supernatant was removed, and the immunoprecipitates were washed with 500 µl 
of: 20 mM Tris-HCl, pH 7.4, 10 mM EDTA, 150 mM NaCl, 1% IGEPAL, 1 mM Na3VO4, 50 
mM NaF, 0.1 mg/L PMSF, 0.3 mg/L aprotinin, and 0.01% protease inhibitor mixture 
(Sigma-Aldrich laboratories). Immunoprecipitated proteins were separated under 
reducing and denaturing conditions by 10% SDS-PAGE and transferred to a polyvinylidene 
difluoride membrane (Millipore). Nonspecific binding was blocked with 5% skim milk in 
PBS–Tween. Membranes were incubated with anti-WAVE1 (1:1000, Sigma-Aldrich 
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Laboratories) or anti-Arp2 (1:900; H-84, Santa Cruz Biotechnology, Santa Cruz, CA) 
antibody. 
 
Quantitative analysis of cell membrane morphology and thickness and of actin fibres 
remodeling 
The remodeling of actin fibres and the morphological changes of the membrane were 
quantified by assessing the intensity of actin fluorescence after conversion of the coloured 
pixels to greyscale using the Leica QWin image analysis and processing software (Leica 
Microsystems, Wetzlar, Germany). This analysis was performed selecting random boxes 
including the extra- and intra-cellular space across the membrane, and the linear intensity 
of the signal was spatially recorded. We sampled five areas per each cell, and we repeated 
this on 40 different cells per experimental condition. Number of spine protrusions per 10 
μM of dendrite length were measured in 5 different dendrites per cell and repeated in 40 
different cells. 
 
Cell immunofluorescence 
Neuronal cells were grown on coverslips. Cells were fixed with 4% paraformaldehyde for 
30 min and permeabilized with 0.1% Triton for 5 min. Blocking was performed with PBS 
containing 3% bovine serum albumin for 30 min. Cells were incubated with anti-WAVE1 
(1:750; Sigma-Aldrich Laboratories) and anti-Arp2 (H-84) (1:300; Santa Cruz 
Biotechnology, Santa Cruz, CA) overnight at 4º C followed by incubation with a 
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fluorescein-conjugated goat anti-rabbit secondary antibody (1:200; Vector Laboratories). 
Then cells were incubated with Texas Red-phalloidin (Sigma) for 30 min. After washing the 
nuclei were counterstained with or 4'-6-diamidino-2-phenylindole (DAPI) (Sigma) and 
mounted with Vectashield mounting medium (Vector Laboratories, Burlingame, CA). 
Immunofluorescence was visualized using an Olympus BX41 microscope and recorded 
with a high-resolution DP70 Olympus digital camera. 
 
Kinase assays 
Neuronal cells were harvested in 20 mM Tris-HCl, 10 mM EDTA, 100 mM NaCl, 0.5% 
IGEPAL, 1 mM Na3VO4, 50 mM NaF, 0.1 mg/L PMSF, 0.3 mg/L aprotinin, and 0.01% 
protease inhibitor mixture (Sigma-Aldrich Laboratories). Equal amounts of cell lysates 
were immunoprecipitated with anti-Cdk5 (2 µg) antibody. Subsequently, 40 µl of 1:1 
Protein-A-agarose was added and the IPs were washed three times with 20 mM Tris-
HCl,10 mM  EDTA, 150 mM NaCl 0.1% IGEPAL, 0.1 mg/ml PMSF. Two additional washes 
were performed in kinase assay buffer (20 mM MOPS, 25 mM -glycerophosphate, 5 mM 
EGTA, 1 mM DTT) and the samples were resuspended in this buffer: 5 g of Histone H1 
de-phosphorylated (H4524, Sigma-Aldrich Laboratories) together with 500 M ATP and 75 
mM MgCl2 were added to each sample and the reaction was started putting the samples 
at 30°C for 20 min. The reaction was stopped on ice and by resuspending the samples in 
Laemmli Buffer. The samples were separated with SDS-PAGE and western analysis was 
performed using Abs recognizing anti-Cdk5 (268-283, Calbiochem) and anti-phospho-
Histone H1.4 (pSer27) (H7664, Sigma-Aldrich Laboratories). 
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Gene silencing with RNA interference 
Two synthetic small interfering RNAs targeting ERα (siRNA SMARTpool ESR1, Dharmacon, 
USA) and WAVE1 (siRNA SMARTpool WAVE1, Dharmacon, USA) were used at the final 
concentration of 50-75 nM. Cortical neurons were treated 48 hours after siRNA 
transfection. The efficacy of gene silencing was checked with western analysis and found 
to be optimal at 48 hours. 
 
Transfection experiments 
The dominant-negative Rac1 T17N 2XMYC-tagged (N-terminus) (Rac1 DN) was from the 
Guthrie cDNA Resource Center (www.cdna.org). The insert was cloned in pcDNA3.1+. The 
plasmid (10 μg) was transfected into cortical neurons using Lipofectamine (Invitrogen, 
Carlsbad, CA). Parallel cells were transfected with empty pcDNA3.1+ plasmid. Cells (60-
70% confluent) were treated 24 h after transfection. 
 
Statistical analysis 
All values are expressed as mean ± SD. Statistical analyses and graphics were done using 
InStat from GraphPad Prism 5 Software. Statistical differences between mean values were 
determined by ANOVA, followed by the Fisher’s protected least significance difference 
(PLSD). 
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FIGURE LEGENDS 
Fig. 1. E2 induces dendritic spine formation and dynamic actin remodeling in cortical 
neurons. A, Neuronal cells were treated for different times with E2 (10 nM). Actin fibers 
were stained with phalloidin linked to Texas Red (red labeling), and nuclei were 
counterstained with 4,6-diamidino-2-phenylindole (blue labeling). The insets show 
dendritic spines at higher magnification from the white boxes. The yellow boxes on the 
cells indicate a sample cellular area that is analyzed in the colored graphs. In these graphs, 
the longitudinal axis represents the gray level, and the horizontal axis indicates pixels. 
Blue, red, and yellow areas indicate the extracellular, plasma membrane, and cytoplasmic 
fractions, respectively. B and C, Mean intensity ratio of actin staining in the 
membrane/cytoplasm in the same experiment. The results are derived from the sampling 
of five areas of the cell membrane of 40 different random cells. Areas of minimum and 
maximum cell membrane thickness were always included. The results are expressed as 
the mean ± SD of the measurements. *, P < 0.05 vs. 0 min. D, Mean number (±SD) of 
dendritic protrusions per 10 µm dendrite length. *, P < 0.05 vs. 0 min. CON, Control. 
 
Fig. 2. Estrogen activates actin remodeling in neurons via WAVE1 and moesin. A, Protein 
extracts from neuronal cells treated with 10 nM E2 for 0–120 min were assayed with 
Western analysis for their overall content of WAVE1, actin, or P-Ser310-, P-Ser397-, and P-
Ser441-WAVE1. B, Densitometric analysis of the P-WAVE1 bands in A. C, Western analysis 
for wild-type and Thr558-P-moesin of neuronal protein extracts treated with E2 (10 nM) 
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for 0–60 min. D, Neuronal cells were treated for different times with E2 (10 nM). Actin 
fibers were stained with phalloidin linked to Texas Red (red labeling), WAVE1 was stained 
with fluorescein isothiocyanate (green labeling), and nuclei were counterstained with 4,6-
diamidino-2-phenylindole (blue labeling). E, Mean ± SD thickness of the cell membrane 
and mean number ± SD of membrane-localized WAVE1, estimated as WAVE1 spots at the 
cell membrane per cell, indicated as the mean of the measurement of 40 different cells 
per condition. F, Mean intensity ratio of actin staining in the membrane/cytoplasm in the 
same experiment. The results are derived from the sampling of five areas of the cell  
membrane of 40 different random cells. Areas of minimum and maximum cell membrane 
thickness were always included. *, P < 0.05 vs. 0 min. G, Neuronal cells were transfected 
with siRNA vs. WAVE1 or with antisense or sense PONs toward moesin for 48 h. WAVE1 
expression and cellular localization status was checked by staining for WAVE1 (fluorescein 
isothiocyanate). Actin fibers were stained with phalloidin-Texas Red, and nuclei were 
counterstained with 4,6-diamidino-2-phenylindole. H, Mean ± SD thickness of the cell 
membrane as well as the intensity of actin staining in the cytoplasm and membrane in the 
same experiment. Technical details are as in E and F. D and G, The white boxes on the cells 
indicate a sample cellular area that is analyzed in the colored graphs. In these graphs, the 
longitudinal axis represents the gray level, and the horizontal axis indicates pixels. Blue, 
red, and yellow areas indicate the extracellular, plasma membrane, and cytoplasmic 
fractions, respectively. CON, Control. 
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Fig. 3. Estrogen signals to WAVE1 via ERα. A, Cortical neurons were exposed for 20 min to 
10 nM E2 in the presence or absence of the pure ER antagonist ICI 182,780 (ICI; 100 nM) 
or with the ERα-selective ligand PPT (10 nM) or the ERβ-selective agonist DPN (10 nM). 
Total phosphorylation of WAVE1 was assayed with Western analysis as a gel migration 
shift in the band. B, Cortical neurons were transfected with siRNA vs. ERα (siRNA ERα) or 
with vehicle, and protein analysis for ERα, ERβ, actin, or wild-type (WAVE1) or P-Ser310-, 
P-Ser397-, and P-Ser441-WAVE1 was performed on cell lysates after treatment for 20 min 
with 10 nM E2. C, The graph displays the quantitative analysis of the intensity of the bands 
in B, obtained as number of photons measured by the ChemiDoc digital imaging system 
and evaluated with the Quantity One Software (Bio-Rad, Hercules, CA). CON, Control. 
 
Fig. 4. ERα signals to WAVE1 via Gαi, Gβ, c-Src, and Rac1. A, Cortical neuronal cells were 
exposed for 20 min to 10 nM E2, in the presence or absence of the G protein inhibitor PTX 
(100 ng/ml) or the c-Src inhibitor PP2 (0.2 µM) or after transfection with dominant-
negative Gα13 or Gαi constructs or siRNAs vs. G1. Wild-type c-Src or P-Tyr416-c-Src were 
assayed in cell extracts. B–D, Neuronal cell protein extracts were immunoprecipitated 
with antibodies toward the indicated G proteins and co-immunoprecipitation of ERα, ERβ, 
and Gαi (C) was tested by Western analysis. E, Cortical neurons were treated for 20 min 
with 10 nM E2, with or without transfection of a dominant-negative Rac1 for 48 h. Rac1, 
wild-type WAVE1, or P-Ser310-, P-Ser397-, and P-Ser441-WAVE1 were assayed in cell 
extracts. CON, Control. 
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Fig. 5. Estrogen signals to WAVE1 via a Gαi-G/c-Src/Rac1/Cdk5 cascade, whereas 
signaling to moesin requires a Gα13/RhoA/ROCK2 pathway. A–C, Cortical neurons were 
treated with E2 in the presence or absence of the specific Cdk5 inhibitor roscovitine (Rosc; 
50 µM) or the c-Src inhibitor PP2 (0.2 µM) or after transfection with a dominant-negative 
Rac1 construct. A and B, Whole protein extracts were immunoprecipitated with an 
antibody against Cdk5. The IPs were used in a kinase assay to phosphorylate histone H1 
(substrate of Cdk5). Phosphorylated histone H1 was detected after Western analysis with 
a phosphospecific antibody. C, Neuronal cell content of Cdk5, WAVE1, and P-Ser310-, P-
Ser397-, and P-Ser441-WAVE1 were assayed with Western analysis. D–F, Cortical neurons 
were exposed to 10 nM E2 for 20 min with or without transfection of WAVE1 constructs 
with inactivating mutations of the Ser310, Ser397, and Ser441 Cdk5 phosphorylation sites. 
D, Western analysis of wild-type or P-Ser310-, P-Ser397-, or P-Ser441-WAVE1 was 
performed. E, Dendritic spine morphology and number were measured with 
immunofluorescence after staining actin fibers with phalloidin/Texas Red. Scale bar, 5 µm. 
F, The graph shows the quantitative analysis of spine density calculated as the number of 
spines per 10 µm dendrite length, normalized vs. nontransfected, vehicle-treated neurons 
and expressed as a percentage. The results are expressed as the mean ± SD. *, P < 0.05 vs. 
E2 in nontransfected cells. G, Cortical neurons were treated with E2 in the presence or 
absence of the G protein inhibitor PTX (100 ng/ml), the c-Src inhibitor PP2 (0.2 µM), the 
Cdk5 inhibitor roscovitine (Rosc; 50 µM), or the Rho-associated kinase inhibitor (ROCK-2) 
Y-27632 (Y, 10 µM) or after transfection with dominant-negative Gα13, Gαi, Rac1, or RhoA 
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constructs or with siRNAs vs. G1. Western analysis for actin, wild-type, and Thr558-P-
moesin, wild-type, and P-Ser310-, or P-Ser397-, or PSer441-WAVE1 was performed.  
 
Fig. 6. Estrogen signaling to WAVE1 turns into membrane localization of the Arp-2/3 
complex. Cortical neurons were treated for 20 min with 10 nM E2 in the presence or 
absence of the Cdk5 inhibitor roscovitine (Rosc; 20 µM) or the c-Src inhibitor PP2 (0.2 µM) 
or after transfection with a dominant-negative Rac1 construct. A, Cells were stained with 
an antibody against Arp-2 (fluorescein isothiocyanate), actin fibers were stained with 
phalloidin linked to Texas Red, and nuclei were counterstained with 4,6-diamidino-2-
phenylindole. Yellow arrows indicate membrane-localized Arp-2. B, Quantification of the 
membrane-localized Arp-2 complexes in the different conditions. Results are expressed as 
percent vs. control cells (mean ± SD). *, P < 0.05 vs. control. Membrane-localized Arp-2 
complexes were counted in 40 different cells. CON, Control. 
 
Fig. 7. Estrogen increases dendritic spine density via WAVE1 and moesin. Cortical 
neurons were incubated in the presence of 10 nM E2 for 20 min in baseline conditions or 
after silencing of WAVE1 with specific siRNAs or of moesin with antisense PONs Sense 
PONs for moesin served as control. A, Dendritic spine morphology and number were 
measured with immunofluorescence after staining actin fibers with phalloidin/Texas Red. 
Scale bar, 5 µm. B, The graph shows the quantitative analysis of spine density expressed as 
the number of spines per 10 µm dendrite length. The results are expressed as the mean ± 
SD. *, P < 0.05 vs. control. CON, Control. 
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Fig. 8. Signaling cascades of ERα to WAVE1 and moesin and dendritic spine formation in 
cortical neurons. Binding of 17-β-estradiol (E2) to the specific membrane receptors (ERα) 
induces phosphorylation of the moesin and WAVE1 cascade. ERα uses the actin 
controllers WAVE1 and moesin to induce a rapid cytoskeletal remodeling that supports 
the formation of dendritic spines. In the presence of E2, ERα recruits a Gαi–Gβ/c–
Src/Rac1/Cdk5/WAVE1 cascade. This turns into WAVE1 phosphorylation and translocation 
to the sites where the actin cytoskeleton and the cell membrane are actively remodeled 
and in the parallel membrane localization of the Arp2/3 protein complex, which is 
responsible for the extension and branching of actin filaments and thus for spine dendrite 
formation. The parallel recruitment of the ERM actin-binding protein, moesin, via a 
Gα13/RhoA/ROCK-2 pathway contributes to the remodeling of the cytoskeleton and is 
required for the estrogen-induced dendritic spine formation. Moesin activation is finely 
modulated by Gαi protein-dependent intracellular pathways. 
 
 
 
 
 
 
A.M. Sanchez                                                   Rapid Signaling of Estrogen in the Brain 
66 
 
SUPPLEMENTAL DATA 
Fig. A. Cortical neurons were transfected with siRNA vs. WAVE1 (siRNAs WAVE1) or with 
vehicle, and protein analysis for WAVE1 or actin was performed on cell lysates after 
treatment for 20 min with estradiol. The graph shows the intensity of the band quantified 
as number of photons measured by the ChemiDoc digital imaging system and evaluated 
with the Quantity One Software (Bio-Rad).  
Fig. B. Cortical neurons were exposed for 20 min to 10 nM E2 in the presence or absence 
of the pure ER antagonist ICI 182,780 (ICI; 100 nM), or with the ERα-selective ligand PPT 
(10 nM) or the ERβ-selective agonist DPN (10 nM). Actin was stained with phalloidin/Texas 
Red, WAVE1 was stained with FITC and the nuclei were counterstained with DAPI. Yellow 
arrows indicate membrane-localized WAVE1.  
Fig. C. Cortical neurons were exposed for 20 min to 10 nM E2 in the presence or absence 
of the pure ER antagonist ICI 182,780 (ICI; 100 nM), or with the ERα-selective ligand PPT 
(10 nM) or the ERβ-selective agonist DPN (10 nM). The bar graph shows the quantification 
of the membrane-localized WAVE1 complexes in the different conditions. * = p < 0.05 vs. 
control. Membrane-localized WAVE1 complexes were counted in 40 different cells. The 
table shows the mean ± SD thickness of the cell membrane as well as the intensity of actin 
staining in the cytoplasm and membrane in the same experiment. The results are derived 
from the sampling of five areas of the cell membrane of 40 different random cells. Areas 
of minimum and maximum cell membrane thickness were always included.  
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Fig. D. The graphs show the intensity of the bands in Fig. 4A in the text. Band intensity was 
quantified as number of photons measured by the ChemiDoc digital imaging system and 
evaluated with the Quantity One Software (Bio-Rad).  
Fig. E-F. Cortical neuronal cells were exposed for 20 min to 10 nM E2, in the presence or 
absence of the c-Src inhibitor, PP2 (0,2 µM) or of the G protein inhibitor PTX (100 ng/ml). 
Other cells were treated after transfection with a dominant-negative Rac1 (RAC1TN17DN) 
for 48 h. WAVE1 intracellular localization was checked by staining with FITC, actin fibres 
were stained with phalloidin-Texas Red and nuclei were counterstained with DAPI. Yellow 
arrows indicate membrane-localized WAVE1 complexes. The bar graph shows the 
quantification of the membrane-localized WAVE1 complexes in the different conditions. * 
= p < 0.05 vs. control. Membrane-localized WAVE1 complexes were counted in 40 
different cells. The table shows the mean ± SD thickness of the cell membrane as well as 
the intensity of actin staining in the cytoplasm and membrane in the same experiment. 
The results are derived from the sampling of five areas of the cell membrane of 40 
different random cells. Areas of minimum and maximum cell membrane thickness were 
always included.  
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